5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.21▲ | 1.21▲ | 1.21▲ | 1.26▼ | 1.18▲ |
MA10 | 1.21▲ | 1.21▼ | 1.24▼ | 1.24▼ | 1.36▼ |
MA20 | 1.21▲ | 1.24▼ | 1.26▼ | 1.19▲ | 3.10▼ |
MA50 | 1.24▼ | 1.27▼ | 1.28▼ | 1.39▼ | 5.67▼ |
MA100 | 1.26▼ | 1.27▼ | 1.21▼ | 3.25▼ | 6.42▼ |
MA200 | 1.29▼ | 1.21▲ | 1.21▼ | 5.29▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | -0.002▼ | -0.008▼ | 0.050▲ | -0.057▼ |
RSI | 43.532▼ | 36.929▼ | 34.531▼ | 42.034▼ | 28.927▼ |
STOCH | 86.111▲ | 18.056▼ | 4.845▼ | 64.044 | 7.146▼ |
WILL %R | -25.000 | -82.353▼ | -86.957▼ | -58.333 | -96.740▼ |
CCI | 19.284 | -76.549 | -85.439 | 12.472 | -51.870 |
MA | $ACRV Price Crossed Below MA(13) | Set Alert |
Thursday, May 29, 2025 03:16 PM
Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information.
|
Monday, May 26, 2025 12:35 PM
O n Friday, Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's ...
|
Wednesday, May 14, 2025 05:00 PM
The latest price target for Acrivon Therapeutics (NASDAQ:ACRV) was reported by Jones Trading on May 16, 2025. The analyst firm set a price target for $0.00 expecting ACRV to fall to within 12 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.25 | 1.27 | 1.19 | 1.20 | 308,059 |
12/06/25 | 1.27 | 1.31 | 1.25 | 1.27 | 300,484 |
11/06/25 | 1.32 | 1.34 | 1.26 | 1.27 | 446,909 |
10/06/25 | 1.30 | 1.32 | 1.27 | 1.295 | 335,401 |
09/06/25 | 1.39 | 1.41 | 1.28 | 1.28 | 601,435 |
06/06/25 | 1.26 | 1.37 | 1.24 | 1.35 | 688,590 |
05/06/25 | 1.24 | 1.27 | 1.22 | 1.25 | 539,490 |
04/06/25 | 1.17 | 1.24 | 1.17 | 1.23 | 562,750 |
03/06/25 | 1.15 | 1.2281 | 1.0801 | 1.16 | 959,922 |
02/06/25 | 1.06 | 1.15 | 1.05 | 1.11 | 754,475 |
|
|
||||
|
|
||||
|
|